Bevacizumab is used in the treatment of colon and rectal cancer, ovarian cancer, cervical cancer, kidney cancer, brain tumors, and non-small cell lung cancer.
How Bevacizumab Works Bevacizumab is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This action inhibits the formation of blood vessels that supply oxygen and nutrients to cancerous cells.
Common side effects of Bevacizumab include exfoliative dermatitis, high blood pressure, nosebleeds, protein in urine, decreased appetite, electrolyte imbalance, peripheral sensory neuropathy, breathlessness, thromboembolism, wound healing complications, ovarian failure, decreased white blood cell count (lymphocytes), low blood platelets, mucosal inflammation, abscess, cellulitis, hypersensitivity, and rectovaginal fistula.